Unlike traditional medications that can take weeks or even months to show results, Spravato offers a unique approach to mental health care.
Non-Invasive Administration: Administered as a simple nasal spray, it offers a more comfortable and convenient alternative to IV ketamine infusions.
Connecting with others who understand.
Practicing awareness and stress reduction.
Improving health through diet, exercise, and sleep.
If you have struggled with depression and found that traditional antidepressants provide little to no relief, you aren’t alone. Spravato® (esketamine) is an FDA-approved nasal spray designed specifically for adults with Treatment-Resistant Depression (TRD) and major depressive disorder with suicidal thoughts or actions.
Feature | Traditional Antidepressants (SSRIs/SNRIs) | Spravato (Esketamine) |
Primary Target | Serotonin, Norepinephrine, Dopamine | Glutamate & NMDA Receptors |
Time to Effect | 4 to 8 Weeks | 24 Hours to 1 Week |
Method | Daily Oral Pill | Supervised Nasal Spray |
Primary Goal | Chemical Balance | Neural Plasticity & Connectivity |
Because Spravato can cause temporary sedation or dissociation, it is administered in our certified clinic under the supervision of a healthcare professional.
Spravato is typically recommended for:
Note on Safety: Common side effects include temporary dissociation (feeling “disconnected”), dizziness, nausea, and increased blood pressure during the session. Spravato is only available through a restricted program called the SPRAVATO® REMS to ensure patient safety.
For more detailed safety information, please visit the official SPRAVATO® website.
Don't let depression hold you back any longer. Contact us today to schedule a consultation and see if Spravato is the right fit for your journey toward wellness